But I digress. Because of that evil man who jacked up the price of a drug because he could and didn't care about the patients, the FDA has moved to see if they can expedite reviews of certain generic drugs (the pound).
"The agency plans to expedite reviews of applications for generic drugs where only one treatment is currently sold."
I like this idea. A lot. Since a generic is essentially the same (but not quite exactly) of existing patented medications, the approval process is much easier than for brand new drugs (or so I believe). The problem is the agency has a backlog of generic medication applications. So now they will see if they can speed some up.
The more generics available, the better. This makes me happy.